MeSH Tree Structures - 2012

C19 - Endocrine System Diseases

• Endocrine System Diseases [C19]
  • Adrenal Gland Diseases [C19.053]
    • Adrenal Cortex Diseases [C19.053.098]
      • Adrenal Cortex Neoplasms [C19.053.098.265]
        • Adrenocortical Adenoma [C19.053.098.265.500]
        • Adrenocortical Carcinoma [C19.053.098.265.750]
    • Adrenal Gland Neoplasms [C19.053.347]
      • Adrenal Cortex Neoplasms [C19.053.347.500]
        • Adrenocortical Adenoma [C19.053.347.500.500]
        • Adrenocortical Carcinoma [C19.053.347.500.750]
    • Adrenal Hyperplasia, Congenital [C19.053.440]
    • Adrenal Insufficiency [C19.053.500]
      • Addison Disease [C19.053.500.263]
      • Adrenoleukodystrophy [C19.053.500.270]
      • Hypoaldosteronism [C19.053.500.480]
      • Waterhouse-Friderichsen Syndrome [C19.053.500.740]
    • Adrenocortical Hyperfunction [C19.053.800]
      • Cushing Syndrome [C19.053.800.367]
      • Hyperaldosteronism [C19.053.800.604]
        • Bartter Syndrome [C19.053.800.604.249]
  • Bone Diseases, Endocrine [C19.149]
  • Diabetes Mellitus [C19.246]
    • Diabetes Complications [C19.246.099]
      • Diabetic Angiopathies [C19.246.099.500]
        • Diabetic Foot [C19.246.099.500.191]
        • Diabetic Retinopathy [C19.246.099.500.382]
      • Diabetic Cardiomyopathies [C19.246.099.625]
      • Diabetic Coma [C19.246.099.750]
        • Hyperglycemic Hyperosmolar Nonketotic Coma [C19.246.099.750.490]
      • Diabetic Ketoacidosis [C19.246.099.812]
      • Diabetic Nephropathies [C19.246.099.875]
      • Diabetic Neuropathies [C19.246.099.937]
        • Diabetic Foot [C19.246.099.937.250]
      • Fetal Macrosomia [C19.246.099.968]
    • Diabetes, Gestational [C19.246.200]
    • Diabetes Mellitus, Experimental [C19.246.240]
    • Diabetes Mellitus, Type 1 [C19.246.267]
      • Wolfram Syndrome [C19.246.267.960]
    • Diabetes Mellitus, Type 2 [C19.246.300]
      • Diabetes Mellitus, Lipoatrophic [C19.246.300.500]
    • Donohue Syndrome [C19.246.537]
    • Prediabetic State [C19.246.774]
  • Dwarfism [C19.297]
    • Congenital Hypothyroidism [C19.297.155]
    • Dwarfism, Pituitary [C19.297.312]
    • Laron Syndrome [C19.297.656]
  • Endocrine Gland Neoplasms [C19.344]
    • Adrenal Gland Neoplasms [C19.344.078]
      • Adrenal Cortex Neoplasms [C19.344.078.265]
        • Adrenocortical Adenoma [C19.344.078.265.500]
        • Adrenocortical Carcinoma [C19.344.078.265.750]
    • Multiple Endocrine Neoplasia [C19.344.400]
      • Multiple Endocrine Neoplasia Type 1 [C19.344.400.500]
      • Multiple Endocrine Neoplasia Type 2a [C19.344.400.505]
      • Multiple Endocrine Neoplasia Type 2b [C19.344.400.510]
    • Ovarian Neoplasms [C19.344.410]
      • Granulosa Cell Tumor [C19.344.410.398]
      • Hereditary Breast and Ovarian Cancer Syndrome [C19.344.410.431]
      • Luteoma [C19.344.410.464]
      • Meigs Syndrome [C19.344.410.531]
      • Sertoli-Leydig Cell Tumor [C19.344.410.648]
      • Thecoma [C19.344.410.765]
    • Pancreatic Neoplasms [C19.344.421]
      • Adenoma, Islet Cell [C19.344.421.249]
        • Insulinoma [C19.344.421.249.500]
      • Carcinoma, Islet Cell [C19.344.421.500]
        • Gastrinoma [C19.344.421.500.124]
        • Glucagonoma [C19.344.421.500.249]
        • Somatostatinoma [C19.344.421.500.500]
        • Vipoma [C19.344.421.500.750]
      • Carcinoma, Pancreatic Ductal [C19.344.421.750]
    • Paraneoplastic Endocrine Syndromes [C19.344.473]
    • Parathyroid Neoplasms [C19.344.525]
    • Pituitary Neoplasms [C19.344.609]
      • ACTH-Secreting Pituitary Adenoma [C19.344.609.145]
        • Nelson Syndrome [C19.344.609.145.500]
      • Growth Hormone-Secreting Pituitary Adenoma [C19.344.609.292]
      • Prolactinoma [C19.344.609.792]
    • Testicular Neoplasms [C19.344.762]
      • Sertoli-Leydig Cell Tumor [C19.344.762.500]
        • Leydig Cell Tumor [C19.344.762.500.249]
        • Sertoli Cell Tumor [C19.344.762.500.500]
    • Thyroid Neoplasms [C19.344.894]
      • Thyroid Nodule [C19.344.894.800]
  • Gonadal Disorders [C19.391]
    • Disorders of Sex Development [C19.391.119]
      • 46, XX Disorders of Sex Development [C19.391.119.064]
        • 46, XX Testicular Disorders of Sex Development [C19.391.119.064.124]
        • Gonadal Dysgenesis, 46,XX [C19.391.119.064.249]
        • Hyperandrogenism [C19.391.119.064.500]
      • 46, XY Disorders of Sex Development [C19.391.119.096]
        • Androgen-Insensitivity Syndrome [C19.391.119.096.500]
        • Denys-Drash Syndrome [C19.391.119.096.562]
        • Frasier Syndrome [C19.391.119.096.624]
        • Gonadal Dysgenesis, 46,XY [C19.391.119.096.687]
          • Gonadoblastoma [C19.391.119.096.687.500]
        • Kallmann Syndrome [C19.391.119.096.750]
        • WAGR Syndrome [C19.391.119.096.875]
      • Adrenogenital Syndrome [C19.391.119.129]
        • Adrenal Hyperplasia, Congenital [C19.391.119.129.500]
        • Hyperandrogenism [C19.391.119.129.750]
      • Gonadal Dysgenesis [C19.391.119.309]
        • Gonadal Dysgenesis, 46,XX [C19.391.119.309.193]
        • Gonadal Dysgenesis, 46,XY [C19.391.119.309.388]
          • Gonadoblastoma [C19.391.119.309.388.500]
        • Gonadal Dysgenesis, Mixed [C19.391.119.309.391]
        • Sexual Infantilism [C19.391.119.309.631]
        • Turner Syndrome [C19.391.119.309.872]
      • Ovotesticular Disorders of Sex Development [C19.391.119.343]
      • Sex Chromosome Disorders of Sex Development [C19.391.119.795]
        • Freemartinism [C19.391.119.795.124]
        • Gonadal Dysgenesis, Mixed [C19.391.119.795.249]
        • Klinefelter Syndrome [C19.391.119.795.500]
        • Turner Syndrome [C19.391.119.795.750]
    • Female Athlete Triad Syndrome [C19.391.240]
    • Hypogonadism [C19.391.482]
      • Eunuchism [C19.391.482.293]
      • Kallmann Syndrome [C19.391.482.600]
      • Klinefelter Syndrome [C19.391.482.629]
      • Sexual Infantilism [C19.391.482.814]
    • Ovarian Diseases [C19.391.630]
      • Anovulation [C19.391.630.050]
      • Oophoritis [C19.391.630.450]
      • Ovarian Cysts [C19.391.630.580]
        • Polycystic Ovary Syndrome [C19.391.630.580.765]
      • Ovarian Hyperstimulation Syndrome [C19.391.630.642]
      • Ovarian Neoplasms [C19.391.630.705]
        • Brenner Tumor [C19.391.630.705.265]
        • Carcinoma, Endometrioid [C19.391.630.705.331]
        • Granulosa Cell Tumor [C19.391.630.705.398]
        • Hereditary Breast and Ovarian Cancer Syndrome [C19.391.630.705.431]
        • Luteoma [C19.391.630.705.464]
        • Meigs Syndrome [C19.391.630.705.531]
        • Sertoli-Leydig Cell Tumor [C19.391.630.705.648]
        • Thecoma [C19.391.630.705.765]
      • Primary Ovarian Insufficiency [C19.391.630.750]
    • Puberty, Delayed [C19.391.690]
    • Puberty, Precocious [C19.391.693]
    • Testicular Diseases [C19.391.829]
      • Cryptorchidism [C19.391.829.258]
      • Orchitis [C19.391.829.493]
      • Testicular Neoplasms [C19.391.829.782]
        • Sertoli-Leydig Cell Tumor [C19.391.829.782.500]
          • Leydig Cell Tumor [C19.391.829.782.500.249]
          • Sertoli Cell Tumor [C19.391.829.782.500.500]
  • Parathyroid Diseases [C19.642]
    • Hyperparathyroidism [C19.642.355]
      • Hyperparathyroidism, Primary [C19.642.355.239]
      • Hyperparathyroidism, Secondary [C19.642.355.480]
        • Renal Osteodystrophy [C19.642.355.480.500]
    • Hypoparathyroidism [C19.642.482]
      • 22q11 Deletion Syndrome [C19.642.482.500]
        • DiGeorge Syndrome [C19.642.482.500.500]
    • Parathyroid Neoplasms [C19.642.713]
  • Pituitary Diseases [C19.700]
    • Diabetes Insipidus [C19.700.159]
      • Diabetes Insipidus, Neurogenic [C19.700.159.750]
      • Wolfram Syndrome [C19.700.159.875]
    • Empty Sella Syndrome [C19.700.320]
    • Hyperpituitarism [C19.700.355]
      • Acromegaly [C19.700.355.179]
      • Gigantism [C19.700.355.528]
      • Hyperprolactinemia [C19.700.355.600]
      • Pituitary ACTH Hypersecretion [C19.700.355.800]
    • Hypopituitarism [C19.700.482]
      • Dwarfism, Pituitary [C19.700.482.311]
    • Inappropriate ADH Syndrome [C19.700.490]
    • Pituitary Apoplexy [C19.700.725]
    • Pituitary Neoplasms [C19.700.734]
      • ACTH-Secreting Pituitary Adenoma [C19.700.734.145]
        • Nelson Syndrome [C19.700.734.145.500]
      • Growth Hormone-Secreting Pituitary Adenoma [C19.700.734.292]
      • Prolactinoma [C19.700.734.792]
  • Polyendocrinopathies, Autoimmune [C19.787]
  • Thyroid Diseases [C19.874]
    • Euthyroid Sick Syndromes [C19.874.255]
    • Goiter [C19.874.283]
      • Goiter, Endemic [C19.874.283.300]
      • Goiter, Nodular [C19.874.283.501]
      • Goiter, Substernal [C19.874.283.601]
      • Graves Disease [C19.874.283.605]
        • Graves Ophthalmopathy [C19.874.283.605.500]
      • Lingual Goiter [C19.874.283.802]
    • Hyperthyroidism [C19.874.397]
      • Graves Disease [C19.874.397.370]
        • Graves Ophthalmopathy [C19.874.397.370.500]
      • Thyrotoxicosis [C19.874.397.685]
        • Thyroid Crisis [C19.874.397.685.905]
    • Hyperthyroxinemia [C19.874.410]
      • Hyperthyroxinemia, Familial Dysalbuminemic [C19.874.410.249]
      • Thyroid Hormone Resistance Syndrome [C19.874.410.500]
    • Hypothyroidism [C19.874.482]
      • Congenital Hypothyroidism [C19.874.482.281]
      • Myxedema [C19.874.482.638]
    • Thyroid Dysgenesis [C19.874.689]
      • Lingual Thyroid [C19.874.689.500]
        • Lingual Goiter [C19.874.689.500.500]
    • Thyroid Neoplasms [C19.874.788]
      • Thyroid Nodule [C19.874.788.800]
    • Thyroiditis [C19.874.871]
      • Thyroiditis, Autoimmune [C19.874.871.102]
        • Hashimoto Disease [C19.874.871.102.500]
        • Postpartum Thyroiditis [C19.874.871.102.750]
      • Thyroiditis, Subacute [C19.874.871.900]
      • Thyroiditis, Suppurative [C19.874.871.910]
    • Thyrotoxicosis [C19.874.902]
      • Thyroid Crisis [C19.874.902.905]
  • Tuberculosis, Endocrine [C19.927]